141 related articles for article (PubMed ID: 31635943)
1. [Localized urticarial rituximab-induced reaction in primary cutaneous marginal zone B-cell lymphoma].
Joly E; Rimond O; Salaun V; Comoz F; Morice C; Dompmartin A; Verneuil L
Ann Dermatol Venereol; 2020 Jan; 147(1):50-52. PubMed ID: 31635943
[No Abstract] [Full Text] [Related]
2. Recurrent localized primary cutaneous marginal-zone B cell lymphoma.
Marmon S; Chu J; Patel R; Meehan S; Pomeranz MK
Dermatol Online J; 2011 Oct; 17(10):27. PubMed ID: 22031653
[TBL] [Abstract][Full Text] [Related]
3. Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma.
Robinson AC; Nachar VR
J Oncol Pharm Pract; 2020 Jul; 26(5):1248-1253. PubMed ID: 31766968
[TBL] [Abstract][Full Text] [Related]
4. A Case Report of Small Lymphocytic Lymphoma Mimicking Primary Cutaneous Marginal Zone Lymphoma With Plasmacytic Differentiation.
Smith SDB; Aggarwal A; Chen W; Nava VE
Am J Dermatopathol; 2021 Oct; 43(10):730-731. PubMed ID: 33606375
[No Abstract] [Full Text] [Related]
5. Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma.
Porkert S; Mai P; Jonak C; Weihsengruber F; Rappersberger K; Bauer W; Simonitsch-Klupp I; Raderer M; Valencak J
Acta Derm Venereol; 2021 Feb; 101(2):adv00383. PubMed ID: 33475146
[TBL] [Abstract][Full Text] [Related]
6. Rituximab-related urticarial reaction overlying primary cutaneous follicle centre lymphoma: histological appearance and pathophysiological hypotheses.
Ingen-Housz-Oro S; Ortonne N; Chosidow O
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):976-8. PubMed ID: 24206369
[No Abstract] [Full Text] [Related]
7. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
8. Rituximab-related urticarial reaction in a patient treated for primary cutaneous B-cell lymphoma.
Errante D; Bernardi D; Bianco A; De Nardi S; Salvagno L
Ann Oncol; 2006 Nov; 17(11):1720-1. PubMed ID: 16731537
[No Abstract] [Full Text] [Related]
9. Darier sign in a teenager with primary cutaneous marginal zone lymphoma.
Leonard N; Lal K; Luffman C; O'Donnell P; Jolley L; Belazarian L
Pediatr Dermatol; 2021 Mar; 38(2):494-496. PubMed ID: 33336458
[TBL] [Abstract][Full Text] [Related]
10. Electrochemotherapy as a novel treatment for primary cutaneous marginal zone B-cell lymphomas.
Gatti A; Stinco G; Trevisini S; di Meo N; Signoretto D; Leonardo E; Bonin S; Trevisan G
Dermatol Ther; 2014; 27(4):244-7. PubMed ID: 24754311
[TBL] [Abstract][Full Text] [Related]
11. A case of rituximab-related urticarial reaction in cutaneous B-cell lymphoma.
Rey J; Wickenhauser S; Ivanov V; Coso D; Gastaut JA; Bouabdallah R
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):210. PubMed ID: 18482321
[No Abstract] [Full Text] [Related]
12. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
[TBL] [Abstract][Full Text] [Related]
13. A Case of Rituximab-Induced Acute Thrombocytopenia in a Patient with Splenic Marginal Zone Lymphoma and Chronic Hepatitis C Virus Infection.
Qureini A; Asif S; Harry S; Madhusudhana S
Am J Case Rep; 2019 Sep; 20():1394-1397. PubMed ID: 31541071
[TBL] [Abstract][Full Text] [Related]
14. Red nose: primary cutaneous marginal zone B-cell lymphoma.
Rosmaninho A; Alves R; Lima M; Lobo I; Amorim I; Selores M
Leuk Res; 2010 May; 34(5):682-4. PubMed ID: 19945162
[No Abstract] [Full Text] [Related]
15. Pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymph tissue: A case report and literature review.
Wu Y; Zhao L; Chai Y
Niger J Clin Pract; 2018 Mar; 21(3):392-394. PubMed ID: 29519992
[TBL] [Abstract][Full Text] [Related]
16. Intralesional Rituximab Injection for Low-Grade Conjunctival Lymphoma Management.
Demirci H; Ozgonul C; Diniz Grisolia AB; Elner VM
Ophthalmology; 2020 Sep; 127(9):1270-1273. PubMed ID: 32336490
[No Abstract] [Full Text] [Related]
17. Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma.
Seker M; Ustaalioğlu BB; Bilici A; Yildirim ME; Kefeli U; Barisik NO; Tamer I; Gumus M
Leuk Res; 2010 Jul; 34(7):e160-3. PubMed ID: 20219245
[No Abstract] [Full Text] [Related]
18. Conjunctival and orbital lymphoma.
Shinder R
Ophthalmology; 2011 Aug; 118(8):1692; author reply 1692, 1692.e1. PubMed ID: 21813098
[No Abstract] [Full Text] [Related]
19. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
Iannitto E; Bellei M; Amorim S; Ferreri AJM; Marcheselli L; Cesaretti M; Haioun C; Mancuso S; Bouabdallah K; Gressin R; Tripodo C; Traverse-Glehen A; Baseggio L; Zupo S; Stelitano C; Castagnari B; Patti C; Alvarez I; Liberati AM; Merli M; Gini G; Cabras MG; Dupuis J; Tessoulin B; Perrot A; Re F; Palombi F; Gulino A; Zucca E; Federico M; Thieblemont C
Br J Haematol; 2018 Dec; 183(5):755-765. PubMed ID: 30407629
[TBL] [Abstract][Full Text] [Related]
20. T-Cell-Rich Recurrence of Primary Cutaneous Follicle Center Lymphoma After Systemic Rituximab: A Diagnostic Pitfall.
Santonja C; Prieto-Torres L; Pérez-Sáenz MLÁ; Requena L; Rodríguez-Pinilla SM
Am J Dermatopathol; 2020 Mar; 42(3):e36-e40. PubMed ID: 31592859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
